Credit: Shutterstock photoAccording to GuruFocus Insider Data , the largest CFO sells during the past week were: Bank of New York Mellon Corp, Medicines, eBay Inc, Morgan Stanley, and PhotoMedex Inc.
Bank of New York Mellon Corp. ( BK ): Vice Chairman and CFO Thomas P. Gibbons Sold 141,510 Shares
Vice Chairman and CFO Thomas P. Gibbons sold 141,510 shares of BK stock on 01/22/2013 at the average price of $26.38. Gibbons owns at least 424,715 shares after this. The price of the stock has increased by 2.65% since.
Bank of New York Mellon Corp. was originally formed as a holding company for The Bank of New York Mellon. Bank Of New York Mellon Corp. has a market cap of $31.76 billion; its shares were traded at around $27.08 with a P/E ratio of 14 and P/S ratio of 2.2. The dividend yield of Bank Of New York Mellon Corp stocks is 1.9%.
Bank of New York Mellon Corp. recently released its fourth quarter 2012 earnings results. For this quarter, the company generated net income of $622 million ($0.53 per diluted share), compared with $505 million ($0.42 per share) in the same quarter of last year. The company also saw a 10% increase in assets year-over-year.
Chairman, President and CEO Gerald L. Hassell sold 353,775 shares of BK stock on 01/22/2013 at the average price of $26.38. Sr. Executive Vice President Kurt D. Woetzel and multiple other insiders also recently sold shares of BK stock.
The Medicines Company ( MDCO ): President and CFO Glenn Sblendorio Sold 125,000 Shares
President and CFO Glenn Sblendorio sold 125,000 shares of MDCO stock on 01/16/2013 at the average price of $30. Glenn Sblendorio owns at least 97,282 shares after this. The price of the stock has increased by 1.13% since.
Medicines reported third quarter 2012 net revenues of $136.8 million, a 13.3% increase over prior year quarter. GAAP net income for this quarter was $9.3 million ($0.17 per share), compared to income of $72.6 million ($1.34 per share) in the same quarter of 2011. Non-GAAP income was $21.8 million ($0.40 per share), compared to $9.2 million ($0.17 per share) prior year quarter.
Medicines was incorporated in Delaware on July 31, 1996. Medicines has a market cap of $1.64 billion; its shares were traded at around $30.34 with a P/E ratio of 33.5 and P/S ratio of 3.2.
CEO Clive Meanwell, Director Robert G. Savage, and Chief Accounting Officer William Bernard O'Connor all sold shares of MDCO stock on 01/16/2013.
eBay Inc. ( EBAY ): Senior Vice President, Finance and CFO Robert Holmes Swan Sold 100,000 Shares
Senior Vice President, Finance and CFO Robert Holmes Swan sold 100,000 shares of eBAY stock on 01/22/2013 at the average price of $53.66. Robert Holmes Swan owns at least 308,803 shares after this. The price of the stock has increased by 5.35% since.
EBay Inc. was formed as a sole proprietorship in September 1995 and was incorporated in California in May 1996. Ebay Inc has a market cap of $73.47 billion; its shares were traded at around $56.53 with a P/E ratio of 19.4 and P/S ratio of 5.5. Ebay Inc. had an annual average earnings growth of 19.9% over the past 10 years. GuruFocus rated Ebay Inc the business predictability rank of 3-star.
eBay Inc. recently reported fourth quarter 2012 net revenue of $4.0 billion, a 18% increase over prior year quarter. GAAP net income was $751 million ($0.57 per diluted share), and non-GAAP net income was $927 million ($0.70 per share).
President and CEO John J. Donahoe sold 250,000 shares of EBAY stock on 01/22/2013 at the average price of $53.61. Senior Vice President Mark T. Carges, and Senior Vice President Alan Lee Marks both also sold shares of eBAY stock over the past week.
Morgan Stanley ( MS ): Deputy CFO and Controller Paul C. Wirth Sold 38,771 Shares
Deputy CFO and Controller Paul C. Wirth sold 38,771 shares of MS stock on 01/22/2013 at the average price of $22.05. Wirth owns at least 232,836 shares after this. The price of the stock has increased by 2.95% since.
Morgan Stanley was originally incorporated under the laws of the State of Delaware in 1981. Morgan Stanley has a market cap of $44.98 billion; its shares were traded at around $22.7 with a P/E ratio of 18.8 and P/S ratio of 1.7. The dividend yield of Morgan Stanley stocks is 0.9%. Morgan Stanley had an annual average earnings growth of 10% over the past five years.
Morgan Stanley reported fourth quarter 2012 net revenues of $7 billion and income from operations of $573 million ($0.28 per diluted share). This compares to revenues of $5.7 billion and net loss of $222 million ($0.13 per share) in the same quarter of last year. Fourth quarter 2012 income included a net tax benefit of $155 million. Net income including discontinued operations was $0.25 per diluted share, compared to a loss of $0.15 per share last year.
Chief Risk Officer Keishi Hotsuki and President Thomas Colm Kelleher also sold shares of MS stock.
PhotoMedex Inc. ( PHMD ): President and CFO Dennis M. Mcgrath Sold 33,596 Shares
President and CFO Dennis M. Mcgrath sold 33,596 shares of PHMD stock on 01/22/2013 at the average price of $15.21. Mcgrath owns at least 200,261 shares after this. The price of the stock has decreased by 1.45% since.
PhotoMedex Inc. is a Nevada corporation incorporated in 2010. Photomedex, Inc. has a market cap of $323 million; its shares were traded at around $14.99 with a P/E ratio of 20.3 and P/S ratio of 1.4.
PhotoMedex Inc. saw third quarter 2012 revenues of $56.7 million, an increase of 63% over prior year quarter. Net income was $ 7.5 million, an increase of 77% over last year.
For the complete list of stocks that Sold by their CFOs, go to: Insider Buys .
Read More:
About GuruFocus: GuruFocus.com tracks the stocks picks and portfolio holdings of the world's best investors. This value investing site offers stock screeners and valuation tools. And publishes daily articles tracking the latest moves of the world's best investors. GuruFocus also provides promising stock ideas in 3 monthly newsletters sent to Premium Members .
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
